Loading
11:30
  1. Utilising Liquid Biopsy for Diagnosis and Surveillance of MRD in Head and Neck Cancer
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Tim Aitman
    Tim Aitman, Director of the Centre for Genomic and Experimental Medicine - University of Edinburgh
12:00
  1. More Details To Be Announced Shortly
    Cancer Diagnostics Stage
    30 mins
12:30
  1. Clinical Testing of Cancer Susceptibility Genes: A Public Health Perspective
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Clare Turnbull
    Clare Turnbull, Professor of Cancer Genetics - Institute of Cancer Research London 
13:00
  1. Lunch Break
    Cancer Diagnostics Stage
    70 mins
14:10
  1. Clinical Applications of ctDNA Testing and Introducing New Indications
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Matthew Krebs
    Matthew Krebs, Cancer Medical Lead - North West Genomic Laboratory Hub
14:40
  1. Liquid Biopsy or Tissue NGS testing in Oncology - Competing Options or a Complementary Strategy?
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Gerald Martin 
    Gerald Martin , Commercial Applications Scientist - Trinity College Dublin (Ireland)
15:10
  1. Precision Diagnostics in Pediatric Cancer Care
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Bastiaan Tops
    Bastiaan Tops, Head of Diagnostic Laboratory - Princess Maxima Center for Pediatric Oncology
15:40
  1. Networking Break
    Cancer Diagnostics Stage
    30 mins
16:10
  1. The Future of Cancer Management: Genomics, Monitoring and Realities
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Michael Hubank
    Michael Hubank, Head of Clinical Genomics - The Royal Marsden NHS Foundation Trust 
16:40
  1. Advancing Cancer Research: Genomic Profiling with QIAseq xHYB Trinity CGP
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Pinar Uysal-Onganer
    Pinar Uysal-Onganer, Reader in Molecular Biology, Cancer Mechanisms and Biomarkers Research Group Leader - University of Westminster
17:10
  1. Clinical Implementation of Genomic Profiling to Advance the Diagnosis of Brain Tumours
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Safa Al-Sarraj
    Safa Al-Sarraj, Head of Neuropathology - King’s College Hospital NHS Foundation Trust
11:30
  1. Liquid Biopsy from Research to Practice in Lung Cancer
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Alastair Greystoke
    Alastair Greystoke, Clinical Senior Lecturer and Honorary Consultant - Newcastle University
12:00
  1. More details to be announced shortly
    Cancer Diagnostics Stage
    30 mins
12:30
  1. The Role of Liquid Biopsy in The NHS Cancer Diagnostic Pathways
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Sian Morgan
    Sian Morgan, All Wales Medical Genomics Service Laboratory Director - NHS Wales
13:10
  1. Lunch Break
    Cancer Diagnostics Stage
    70 mins
14:15
  1. Molecular Residual Disease Monitoring in Breast Cancer
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Isaac Garcia-Murillas
    Isaac Garcia-Murillas, Senior Staff Scientist - Institute of Cancer Research
14:45
  1. Sponsored Slot Available
    Cancer Diagnostics Stage
    30 mins
15:15
  1. The SMPaeds2 Study: The Power of ctDNA in Paediatric Cancer
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Sally George
    Sally George, Paediatric Oncologist and Group Leader - The Institute of Cancer Research
15:50
  1. Networking Break
    Cancer Diagnostics Stage
    30 mins
16:15
  1. Blood-Based Immune Profiling for Early Detection of Brain Cancer
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Jamie Blundell
    Jamie Blundell, Group Leader - University of Cambridge
16:45
  1. MCED - DNA Methylation-Based Liquid Biopsy for Early Detection of HPV-Related Cancers
    Cancer Diagnostics Stage
    30 mins
    Speakers
    Speaker image for Belinda Nedjai
    Belinda Nedjai, Director of the Molecular Epidemiology Laboratory - Queen Mary University of London